Industrial perspectives on brain-computer interface technology

Neuromodulation therapies offer a unique opportunity for translating brain-computer interface (BCI) technologies into a clinical setting. Several diseases such as Parkinson's disease are effectively treated by invasive device stimulation therapies, and the addition of sensing and algorithm tech...

Full description

Saved in:
Bibliographic Details
Published inHandbook of Clinical Neurology Vol. 168; pp. 341 - 352
Main Authors Pulliam, Christopher L., Stanslaski, Scott R., Denison, Timothy J.
Format Book Chapter Journal Article
LanguageEnglish
Published Netherlands Elsevier Health Sciences 2020
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Neuromodulation therapies offer a unique opportunity for translating brain-computer interface (BCI) technologies into a clinical setting. Several diseases such as Parkinson's disease are effectively treated by invasive device stimulation therapies, and the addition of sensing and algorithm technology is an obvious evolutionary expansion of capabilities. In addition, this infrastructure might enable a roadmap of novel BCI technologies. While the initial applications are focused on epilepsy and movement disorders, the technology is potentially transferable to a broader base of disorders, including stroke and rehabilitation. The ultimate potential of BCI technology will be determined by forthcoming chronic evaluation in multiple neurologic disorders.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISBN:9780444639349
0444639349
ISSN:0072-9752
DOI:10.1016/B978-0-444-63934-9.00025-1